Informações:
Falhas:
ID
31875
Descrição
A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate; ODM derived from: https://clinicaltrials.gov/show/NCT00845832
Link
https://clinicaltrials.gov/show/NCT00845832
Palavras-chave
Versões (1)
- 05/10/2018 05/10/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
5 de outubro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Rheumatoid Arthritis NCT00845832
Eligibility Rheumatoid Arthritis NCT00845832
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00845832
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients, 18-65 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis, functional status i-iii;
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Swollen 28 joint count | Tender 28 joint count
Item
sjc>=4 (28 joint count) and tjc>=4 (28 joint count) at screening and baseline;
boolean
C2711873 (UMLS CUI [1])
C2711398 (UMLS CUI [2])
C2711398 (UMLS CUI [2])
Rheumatoid factor positive | Anti-cyclic citrullinated peptide antibody positive
Item
rf and/or anti-ccp positive;
boolean
C0151379 (UMLS CUI [1])
C2609056 (UMLS CUI [2])
C2609056 (UMLS CUI [2])
Anti-tumor necrosis factor alpha drug Quantity failed | infliximab | Etanercept | adalimumab
Item
may have failed up to 1 approved anti-tnf agent (infliximab, etanercept or adalimumab);
boolean
C1562242 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
Methotrexate Dose Stable U/week | Response Inadequate
Item
inadequate response to methotrexate, at a dose of 7.5-25mg weekly for at least 12 weeks, at a stable dose for past 4 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement
Item
rheumatic autoimmune disease other than rheumatoid arthritis, or significant systemic involvement secondary to rheumatoid arthritis;
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0494896 (UMLS CUI [3])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0494896 (UMLS CUI [3])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
history of, or current, inflammatory joint disease other than rheumatoid arthritis;
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Juvenile arthritis | Juvenile rheumatoid arthritis | Age
Item
diagnosis of juvenile idiopathic arthritis and/or rheumatoid arthritis before age 16;
boolean
C3495559 (UMLS CUI [1])
C3714757 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C3714757 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Heart Disease | Lung disease
Item
significant cardiac or pulmonary disease;
boolean
C0018799 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
C0024115 (UMLS CUI [2])
Biological agent Rheumatoid Arthritis | Exception Infliximab | Exception Etanercept | Exception Adalimumab
Item
previous treatment with any biologic agent for rheumatoid arthritis (other than infliximab, etanercept or adalimumab).
boolean
C0005515 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0666743 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0717758 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1122087 (UMLS CUI [4,2])
C0003873 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0666743 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0717758 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1122087 (UMLS CUI [4,2])